A Survey on Nutritional Pattern in Women with Breast Fibrocystic Changes in Isfahan City, Iran

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Community and Family Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Midwife, Health Center No. 2, Vice Chancellor for Health, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Fibrocystic breast is one of the most common diseases of the breast. So far, several surveys have investigated the relationship between breast fibrocystic changes and nutritional pattern. Present study aimed to determine the food pattern in women with breast fibrocystic changes in Isfahan City, Iran.Methods: In present study, 208 cases with benign breast disease were selected from the Molla Sadra health center in Isfahan. Demographic information, type of breast cysts, and nutritional pattern were gathered according to the approved questionnaire of Iranian Ministry of Health.Findings: There was significant relation between height, weight, and body mass index with breast fibrocystic changes (P < 0.050 for all). Moreover, there was significant relation between fast food consumption and aforementioned changes (P < 0.050). There was not significant relation between other groups of foods such as dairy, fruits, and vegetable with breast fibrocystic alterations.Conclusion: Based on our investigation, reducing the consumption of fast foods and increasing physical activities are two of crucial parameters for management of breast fibrocystic changes in women.

Keywords

References

  1. Sasaki J, Geletzke A, Kass RB, Klimberg VS, Copeland EM, Bland KI. Etiology and management of benign breast disease. In: Bland KI, Copeland EM, Klimberg VS, Gradishar WJ, editors. The Breast. 5th ed. Philadelphia, PA: Elsevier; 2018. p. 79-92.
  2. Manoochehri J, Abdollahi A, Tajik A. Epidemiological study of breast tumors in Iranian patients. 2018.
  3. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 1998; 122(12): 1053-5.
  4. Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc 2004; 79(3): 353-72.
  5. Egwuonwu OA, Anyanwu SN, Chianakwana GU, Ihekwoaba EC. Breast pain: Clinical pattern and aetiology in a breast clinic in Eastern Nigeria. Niger J Surg 2016; 22(1): 9-11.
  6. Brkic M, Vujovic S, Ivanisevic MF, Ivovic M, Gajic MT, Marina L, et al. The influence of progesterone gel therapy in the treatment of fibrocystic breast disease. Open J Obstet Gynecol 2016; 6(5): 334-41.
  7. Irgebay Z, Yeszhan B, Sen B, Tuleukhanov S, Brooks AD, Sensenig R, et al. Danazol alters mitochondria metabolism of fibrocystic breast Mcf10A cells. Breast 2017; 35: 55-62.
  8. Arslan M, Kucukerdem HS, Can H, Tarcan E. retrospective analysis of women with only mastalgia. J Breast Health 2016; 12(4): 151-4.
  9. Hislop TG, Band PR, Deschamps M, Ng V, Coldman AJ, Worth AJ, et al. Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 1990; 131(2): 263-70.
  10. Groen JW, Grosfeld S, Bramer WM, Ernst MF, Mullender MM. Cyclic and non-cyclic breast-pain: A systematic review on pain reduction, side effects, and quality of life for various treatments. Eur J Obstet Gynecol Reprod Biol 2017; 219: 74-93.
  11. Wu C, Ray RM, Lin MG, Gao DL, Horner NK, Nelson ZC, et al. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol 2004; 160(10): 945-60.
  12. Liebman B. Caffeine and breast disease. Nutrition Action Health Letter (USA) 1985. Available from: URL: http://agris.fao.org/agris-search/search.do?recordID= US8724638
  13. Mourouti N, Kontogianni MD, Papavagelis C, Panagiotakos DB. Diet and breast cancer: A systematic review. Int J Food Sci Nutr 2015; 66(1): 1-42.
  14. Ingram DM, Nottage E, Roberts T. The role of diet in the development of breast cancer: A case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. Br J Cancer 1991; 64(1): 187-91.
  15. Hair BY, Troester MA, Edmiston SN, Parrish EA, Robinson WR, Wu MC, et al. Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors. Cancer Epidemiol Biomarkers Prev 2015; 24(3): 580-6.
  16. Rossi EL, Bowers LW, Khatib SA, Doerstling SS, Hursting SD. Pre-clinical findings on obesity reversal and breast cancer progression: Targeting persistent inflammation. Cancer Res 2016; 76(4 Suppl): 2-05.
  17. Matthews SB, Thompson HJ. The obesity-breast cancer conundrum: An analysis of the issues. Int J Mol Sci 2016; 17(6).
  18. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14(7): 1686-91.
  19. Berkey CS, Rosner B, Tamimi RM, Willett WC, Hickey M, Toriola A, et al. Body size from birth through adolescence in relation to risk of benign breast disease in young women. Breast Cancer Research and Treatment 2017; 162(1): 139-49.
  20. Li J, Han X. Adipocytokines and breast cancer. Curr Probl Cancer 2018; 42(2): 208-14.
  21. Sambiasi D, De SS, Digennaro M, Pilato B, Paradiso A, Tommasi S. Adipokines in hereditary breast cancer patients and healthy relatives. Oncotarget 2017; 8(60): 101255-61.
  22. Saeedi Borujeni MJ, Esfandiary E, Taheripak G, Codoner-Franch P, Alonso-Iglesias E, Mirzaei H. Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome. J Cell Biochem 2018; 119(2): 1257-72.
  23. Rohan TE, Negassa A, Caan B, Chlebowski RT, Curb JD, Ginsberg M, et al. Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res (Phila) 2008; 1(4): 275-84.
  24. Li W, Ray RM, Lampe JW, Lin MG, Gao DL, Wu C, et al. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int J Cancer 2005; 115(6): 981-93.
  25. Rohan TE, Cook MG, Potter JD, McMichael AJ. A case-control study of diet and benign proliferative epithelial disorders of the breast. Cancer Res 1990; 50(11): 3176-81.
  26. Tiznobeyk Z, Sheikhi MZ, Qorbani M, Koohdani F, Sotoudeh G, Khajehnasiri F, et al. Dietary patterns and benign breast diseases: a case-control study. Br J Nutr 2016; 116(2): 353-9.
  27. Esmaillzadeh A, Azadbakht L. Dairy consumption and circulating levels of inflammatory markers among Iranian women. Public Health Nutr 2010; 13(9): 1395-402.
  28. Bassir M, Laborie S, Lapillonne A, Claris O, Chappuis MC, Salle BL. Vitamin D deficiency in Iranian mothers and their neonates: A pilot study. Acta Paediatr 2001; 90(5): 577-9.
Journal of Isfahan Medical School
Volume 36, Issue 492 - Serial Number 492
July and August 2018
Pages 942-948

Files

History

  • Receive Date: 14 July 2018
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics